Global Neurosyphilis Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 120 pages | ID: G5A9B303031GEN
GlobalInfoResearch

Abstracts

Neurosyphilis is an infection of the brain or spinal cord caused by the spirochete Treponema pallidum. It usually occurs in people who have had chronic, untreated syphilis, usually about 10 to 20 years after first infection and develops in about 25%?40% of those who are not treated. The United States' Centers for Disease Control and Prevention (CDC) advises that neurosyphilis can occur at any stage of a syphilis infection.

SCOPE OF THE REPORT:

This report studies the Neurosyphilis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Neurosyphilis market by product type and applications/end industries.
Neurosyphilis has four different forms: asymptomatic, meningovascular, tabes dorsalis, and general paresis. In rare instances, active neurosyphilis can mimic Alzheimer's disease. In addition to evaluation of any symptoms and signs, various blood tests can be done. Additional tests to look for problems with the nervous system may include Cerebral angiogram, Head CT scan, Lumbar puncture and MRI scan of the brain, brainstem, or spinal cord.
The global Neurosyphilis market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Neurosyphilis.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Abbott
• Bayer
• Eli Lilly and Company
• GlaxoSmithKline
• Novartis
• Pfizer
• Sanofi

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Asymptomatic Neurosyphilis
• Meningeal Neurosyphilis
• Meningovascular Neurosyphilis
• General Paresis
• Tabes Dorsalis

Market Segment by Applications, can be divided into

• Hospital And Clinics
• Medical Research Centers
• Academic Institutes

Contents

1 NEUROSYPHILIS MARKET OVERVIEW

1.1 Product Overview and Scope of Neurosyphilis
1.2 Classification of Neurosyphilis by Types
  1.2.1 Global Neurosyphilis Revenue Comparison by Types (2017-2023)
  1.2.2 Global Neurosyphilis Revenue Market Share by Types in 2017
  1.2.3 Asymptomatic Neurosyphilis
  1.2.4 Meningeal Neurosyphilis
  1.2.5 Meningovascular Neurosyphilis
  1.2.6 General Paresis
  1.2.7 Tabes Dorsalis
1.3 Global Neurosyphilis Market by Application
  1.3.1 Global Neurosyphilis Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospital And Clinics
  1.3.3 Medical Research Centers
  1.3.4 Academic Institutes
1.4 Global Neurosyphilis Market by Regions
  1.4.1 Global Neurosyphilis Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Neurosyphilis Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Neurosyphilis Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neurosyphilis Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Neurosyphilis Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neurosyphilis Status and Prospect (2013-2023)
1.5 Global Market Size of Neurosyphilis (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Abbott
  2.1.1 Business Overview
  2.1.2 Neurosyphilis Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Abbott Neurosyphilis Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bayer
  2.2.1 Business Overview
  2.2.2 Neurosyphilis Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Bayer Neurosyphilis Revenue, Gross Margin and Market Share (2016-2017)
2.3 Eli Lilly and Company
  2.3.1 Business Overview
  2.3.2 Neurosyphilis Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Eli Lilly and Company Neurosyphilis Revenue, Gross Margin and Market Share (2016-2017)
2.4 GlaxoSmithKline
  2.4.1 Business Overview
  2.4.2 Neurosyphilis Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 GlaxoSmithKline Neurosyphilis Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis
  2.5.1 Business Overview
  2.5.2 Neurosyphilis Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Novartis Neurosyphilis Revenue, Gross Margin and Market Share (2016-2017)
2.6 Pfizer
  2.6.1 Business Overview
  2.6.2 Neurosyphilis Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Pfizer Neurosyphilis Revenue, Gross Margin and Market Share (2016-2017)
2.7 Sanofi
  2.7.1 Business Overview
  2.7.2 Neurosyphilis Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Sanofi Neurosyphilis Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL NEUROSYPHILIS MARKET COMPETITION, BY PLAYERS

3.1 Global Neurosyphilis Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Neurosyphilis Players Market Share
  3.2.2 Top 10 Neurosyphilis Players Market Share
3.3 Market Competition Trend

4 GLOBAL NEUROSYPHILIS MARKET SIZE BY REGIONS

4.1 Global Neurosyphilis Revenue and Market Share by Regions
4.2 North America Neurosyphilis Revenue and Growth Rate (2013-2018)
4.3 Europe Neurosyphilis Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Neurosyphilis Revenue and Growth Rate (2013-2018)
4.5 South America Neurosyphilis Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Neurosyphilis Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA NEUROSYPHILIS REVENUE BY COUNTRIES

5.1 North America Neurosyphilis Revenue by Countries (2013-2018)
5.2 USA Neurosyphilis Revenue and Growth Rate (2013-2018)
5.3 Canada Neurosyphilis Revenue and Growth Rate (2013-2018)
5.4 Mexico Neurosyphilis Revenue and Growth Rate (2013-2018)

6 EUROPE NEUROSYPHILIS REVENUE BY COUNTRIES

6.1 Europe Neurosyphilis Revenue by Countries (2013-2018)
6.2 Germany Neurosyphilis Revenue and Growth Rate (2013-2018)
6.3 UK Neurosyphilis Revenue and Growth Rate (2013-2018)
6.4 France Neurosyphilis Revenue and Growth Rate (2013-2018)
6.5 Russia Neurosyphilis Revenue and Growth Rate (2013-2018)
6.6 Italy Neurosyphilis Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC NEUROSYPHILIS REVENUE BY COUNTRIES

7.1 Asia-Pacific Neurosyphilis Revenue by Countries (2013-2018)
7.2 China Neurosyphilis Revenue and Growth Rate (2013-2018)
7.3 Japan Neurosyphilis Revenue and Growth Rate (2013-2018)
7.4 Korea Neurosyphilis Revenue and Growth Rate (2013-2018)
7.5 India Neurosyphilis Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Neurosyphilis Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA NEUROSYPHILIS REVENUE BY COUNTRIES

8.1 South America Neurosyphilis Revenue by Countries (2013-2018)
8.2 Brazil Neurosyphilis Revenue and Growth Rate (2013-2018)
8.3 Argentina Neurosyphilis Revenue and Growth Rate (2013-2018)
8.4 Colombia Neurosyphilis Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE NEUROSYPHILIS BY COUNTRIES

9.1 Middle East and Africa Neurosyphilis Revenue by Countries (2013-2018)
9.2 Saudi Arabia Neurosyphilis Revenue and Growth Rate (2013-2018)
9.3 UAE Neurosyphilis Revenue and Growth Rate (2013-2018)
9.4 Egypt Neurosyphilis Revenue and Growth Rate (2013-2018)
9.5 Nigeria Neurosyphilis Revenue and Growth Rate (2013-2018)
9.6 South Africa Neurosyphilis Revenue and Growth Rate (2013-2018)

10 GLOBAL NEUROSYPHILIS MARKET SEGMENT BY TYPE

10.1 Global Neurosyphilis Revenue and Market Share by Type (2013-2018)
10.2 Global Neurosyphilis Market Forecast by Type (2018-2023)
10.3 Asymptomatic Neurosyphilis Revenue Growth Rate (2013-2023)
10.4 Meningeal Neurosyphilis Revenue Growth Rate (2013-2023)
10.5 Meningovascular Neurosyphilis Revenue Growth Rate (2013-2023)
10.6 General Paresis Revenue Growth Rate (2013-2023)
10.7 Tabes Dorsalis Revenue Growth Rate (2013-2023)

11 GLOBAL NEUROSYPHILIS MARKET SEGMENT BY APPLICATION

11.1 Global Neurosyphilis Revenue Market Share by Application (2013-2018)
11.2 Neurosyphilis Market Forecast by Application (2018-2023)
11.3 Hospital And Clinics Revenue Growth (2013-2018)
11.4 Medical Research Centers Revenue Growth (2013-2018)
11.5 Academic Institutes Revenue Growth (2013-2018)

12 GLOBAL NEUROSYPHILIS MARKET SIZE FORECAST (2018-2023)

12.1 Global Neurosyphilis Market Size Forecast (2018-2023)
12.2 Global Neurosyphilis Market Forecast by Regions (2018-2023)
12.3 North America Neurosyphilis Revenue Market Forecast (2018-2023)
12.4 Europe Neurosyphilis Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Neurosyphilis Revenue Market Forecast (2018-2023)
12.6 South America Neurosyphilis Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Neurosyphilis Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Neurosyphilis Picture
Table Product Specifications of Neurosyphilis
Table Global Neurosyphilis and Revenue (Million USD) Market Split by Product Type
Figure Global Neurosyphilis Revenue Market Share by Types in 2017
Figure Asymptomatic Neurosyphilis Picture
Figure Meningeal Neurosyphilis Picture
Figure Meningovascular Neurosyphilis Picture
Figure General Paresis Picture
Figure Tabes Dorsalis Picture
Table Global Neurosyphilis Revenue (Million USD) by Application (2013-2023)
Figure Neurosyphilis Revenue Market Share by Applications in 2017
Figure Hospital And Clinics Picture
Figure Medical Research Centers Picture
Figure Academic Institutes Picture
Table Global Market Neurosyphilis Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Neurosyphilis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Neurosyphilis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Neurosyphilis Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Neurosyphilis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Neurosyphilis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Neurosyphilis Revenue (Million USD) and Growth Rate (2013-2023)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Neurosyphilis Type and Applications
Table Abbott Neurosyphilis Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Neurosyphilis Type and Applications
Table Bayer Neurosyphilis Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly and Company Neurosyphilis Type and Applications
Table Eli Lilly and Company Neurosyphilis Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Neurosyphilis Type and Applications
Table GlaxoSmithKline Neurosyphilis Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Neurosyphilis Type and Applications
Table Novartis Neurosyphilis Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Neurosyphilis Type and Applications
Table Pfizer Neurosyphilis Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Neurosyphilis Type and Applications
Table Sanofi Neurosyphilis Revenue, Gross Margin and Market Share (2016-2017)
Table Global Neurosyphilis Revenue (Million USD) by Players (2013-2018)
Table Global Neurosyphilis Revenue Share by Players (2013-2018)
Figure Global Neurosyphilis Revenue Share by Players in 2016
Figure Global Neurosyphilis Revenue Share by Players in 2017
Figure Global Top 5 Players Neurosyphilis Revenue Market Share in 2017
Figure Global Top 10 Players Neurosyphilis Revenue Market Share in 2017
Figure Global Neurosyphilis Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Neurosyphilis Revenue (Million USD) by Regions (2013-2018)
Table Global Neurosyphilis Revenue Market Share by Regions (2013-2018)
Figure Global Neurosyphilis Revenue Market Share by Regions (2013-2018)
Figure Global Neurosyphilis Revenue Market Share by Regions in 2017
Figure North America Neurosyphilis Revenue and Growth Rate (2013-2018)
Figure Europe Neurosyphilis Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Neurosyphilis Revenue and Growth Rate (2013-2018)
Figure South America Neurosyphilis Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Neurosyphilis Revenue and Growth Rate (2013-2018)
Table North America Neurosyphilis Revenue by Countries (2013-2018)
Table North America Neurosyphilis Revenue Market Share by Countries (2013-2018)
Figure North America Neurosyphilis Revenue Market Share by Countries (2013-2018)
Figure North America Neurosyphilis Revenue Market Share by Countries in 2017
Figure USA Neurosyphilis Revenue and Growth Rate (2013-2018)
Figure Canada Neurosyphilis Revenue and Growth Rate (2013-2018)
Figure Mexico Neurosyphilis Revenue and Growth Rate (2013-2018)
Table Europe Neurosyphilis Revenue (Million USD) by Countries (2013-2018)
Figure Europe Neurosyphilis Revenue Market Share by Countries (2013-2018)
Figure Europe Neurosyphilis Revenue Market Share by Countries in 2017
Figure Germany Neurosyphilis Revenue and Growth Rate (2013-2018)
Figure UK Neurosyphilis Revenue and Growth Rate (2013-2018)
Figure France Neurosyphilis Revenue and Growth Rate (2013-2018)
Figure Russia Neurosyphilis Revenue and Growth Rate (2013-2018)
Figure Italy Neurosyphilis Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Neurosyphilis Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Neurosyphilis Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Neurosyphilis Revenue Market Share by Countries in 2017
Figure China Neurosyphilis Revenue and Growth Rate (2013-2018)
Figure Japan Neurosyphilis Revenue and Growth Rate (2013-2018)
Figure Korea Neurosyphilis Revenue and Growth Rate (2013-2018)
Figure India Neurosyphilis Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Neurosyphilis Revenue and Growth Rate (2013-2018)
Table South America Neurosyphilis Revenue by Countries (2013-2018)
Table South America Neurosyphilis Revenue Market Share by Countries (2013-2018)
Figure South America Neurosyphilis Revenue Market Share by Countries (2013-2018)
Figure South America Neurosyphilis Revenue Market Share by Countries in 2017
Figure Brazil Neurosyphilis Revenue and Growth Rate (2013-2018)
Figure Argentina Neurosyphilis Revenue and Growth Rate (2013-2018)
Figure Colombia Neurosyphilis Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Neurosyphilis Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Neurosyphilis Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Neurosyphilis Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Neurosyphilis Revenue Market Share by Countries in 2017
Figure Saudi Arabia Neurosyphilis Revenue and Growth Rate (2013-2018)
Figure UAE Neurosyphilis Revenue and Growth Rate (2013-2018)
Figure Egypt Neurosyphilis Revenue and Growth Rate (2013-2018)
Figure Nigeria Neurosyphilis Revenue and Growth Rate (2013-2018)
Figure South Africa Neurosyphilis Revenue and Growth Rate (2013-2018)
Table Global Neurosyphilis Revenue (Million USD) by Type (2013-2018)
Table Global Neurosyphilis Revenue Share by Type (2013-2018)
Figure Global Neurosyphilis Revenue Share by Type (2013-2018)
Figure Global Neurosyphilis Revenue Share by Type in 2017
Table Global Neurosyphilis Revenue Forecast by Type (2018-2023)
Figure Global Neurosyphilis Market Share Forecast by Type (2018-2023)
Figure Global Asymptomatic Neurosyphilis Revenue Growth Rate (2013-2018)
Figure Global Meningeal Neurosyphilis Revenue Growth Rate (2013-2018)
Figure Global Meningovascular Neurosyphilis Revenue Growth Rate (2013-2018)
Figure Global General Paresis Revenue Growth Rate (2013-2018)
Figure Global Tabes Dorsalis Revenue Growth Rate (2013-2018)
Table Global Neurosyphilis Revenue by Application (2013-2018)
Table Global Neurosyphilis Revenue Share by Application (2013-2018)
Figure Global Neurosyphilis Revenue Share by Application (2013-2018)
Figure Global Neurosyphilis Revenue Share by Application in 2017
Table Global Neurosyphilis Revenue Forecast by Application (2018-2023)
Figure Global Neurosyphilis Market Share Forecast by Application (2018-2023)
Figure Global Hospital And Clinics Revenue Growth Rate (2013-2018)
Figure Global Medical Research Centers Revenue Growth Rate (2013-2018)
Figure Global Academic Institutes Revenue Growth Rate (2013-2018)
Figure Global Neurosyphilis Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Neurosyphilis Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Neurosyphilis Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Neurosyphilis Revenue Market Forecast (2018-2023)
Figure Europe Neurosyphilis Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Neurosyphilis Revenue Market Forecast (2018-2023)
Figure South America Neurosyphilis Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Neurosyphilis Revenue Market Forecast (2018-2023)